Biopolym. Cell. 1989; 5(1):96-99.
Short Communications
The influence of the transforming growth factor-p, epidermal growth factor and insulin on cellular proliferation in semisolid agar medium
1Stoika R. S., 1Sushelnitsky S. I., 1Kusen' S. I.
  1. Lvov Branch of A. V. Palladin Institute of Biochemistry, Academy of Sciences of the Ukrainian SSR
    Lvov, USSR

Abstract

The transforming growth factor-f5 (TGF-J3), which was isolated and purified by the authors from pig thrombocytes, epidermal growth factor (EGF) and insulin are studied for their effect on cellular proliferation in semisolid culture medium with 0.33 % agar. The lines N1H-3T3 and Swiss-373 of the mouse fibroblasts and rat NRK-49F cells are tested. It was shown that TGF-fi (0.05-50.0 ng/ml) stimulates multiplication of the cells of the mentioned lines only in the presence of EGF (2.5 ng/ml). Synergism in the action of two growth factors is detected when NIH-3T3 and NRK-49F cells are used but it is less expressed in the case of Swiss-3T3 cells. Insulin (1 |ig/ml) intensifies the growth stimulating activity of EGF plus TGF-|3 mixture for Swiss-373 cells bult it inhibits this activity when NIH-373 cells are tested. Thus, the same combination of growth factors can inhibit the expression of phenotypic transformation in one type of cells and can intensify it in other cells being closely related by their origin.

References

[1] Kusen' SI, Stoika RS. Molecular mechanisms in the action of polypeptide growth factors. Moscow, Nauka, 1985; 236 p.
[2] Kalyunov VN. Nerve growth factor. Minsk: Nauka i tekhnika, 1984; 216 p.
[3] Nikol'skiy NN, Sorkin AD, Sorokin AB.Epidermal growth factor. Leningrad, Nauka, 1987; 200 p.
[4] de Larco JE, Todaro GJ. Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci U S A. 1978;75(8):4001-5.
[5] Roberts AB, Sporn MB. Transforming growth factors. Cancer Surv. 1985;4(4):683-705.
[6] Goustin AS, Leof EB, Shipley GD, Moses HL. Growth factors and cancer. Cancer Res. 1986;46(3):1015-29.
[7] Rizzino A, Ruff E, Rizzino H. Induction and modulation of anchorage-independent growth by platelet-derived growth factor, fibroblast growth factor, and transforming growth factor-beta. Cancer Res. 1986;46(6):2816-20.
[8] Massague J, Kelly B, Mottola C. Stimulation by insulin-like growth factors is required for cellular transformation by type beta transforming growth factor. J Biol Chem. 1985;260(8):4551-4.
[9] Sporn MB, Roberts AB, Wakefield LM, Assoian RK. Transforming growth factor-beta: biological function and chemical structure. Science. 1986;233(4763):532-4.
[10] Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol. 1987;105(3):1039-45.
[11] Sushel'nytskyi SI, Stoika RC, Garas'ko SI. Partial purification and some properties of beta-type transforming growth factor platelet pig. Abstracts of V Ukr. Biochem. Congr. (Ivano-Frankivsk, 1987). Kyiv, 1987; Pt 2:249.
[12] Cytokine bulletin. Minneapolis: R and D Systems, 1987. Vol. 1-8 p.
[13] Rizzino A. Behavior of transforming growth factors in serum-free media: an improved assay for transforming growth factors. In Vitro. 1984;20(10):815-22.
[14] Kaplan PL, Ozanne B. Cellular responsiveness to growth factors correlates with a cell's ability to express the transformed phenotype. Cell. 1983;33(3):931-8.
[15] Barkan RS, Nikol'ski? NN. [Minimally transformed 3T3 cell lines as an object for research on the mechanisms of proliferation]. Tsitologiia. 1985;27(1):5-27. Review. Russian.